Public release date: 10-May-2011 – Request Repost Drug regulators are protecting profits over patients, warn researchers Analysis: Opening up data at the European Medicines Agency Medicines regulators are protecting drug company profits rather than the lives and welfare of patients… Read More ›
Pharmaceutical industry
Drug company CEO hangs up on charity head who called with offer to pay $50,000 for life-saving treatment for a dying 7-year-old boy
– the company received $72 million in federal funding to develop Brincidofovir The CEO of pharmaceutical company that could supply a life-saving anti-viral drugs to a 7-year-old cancer sufferer refuses to hand the drugs over Chimerix chief Kenneth Moch hung… Read More ›
Pharmaceuticals: A market for producing ‘lemons’ and serious harm
EEV: Re-Post Request Public release date: 17-Aug-2010 – they spend two to three times more on marketing than on research to persuade doctors to prescribe these new drugs – Doctors may get misleading information and then misinform patients about the… Read More ›
Are you Big Pharma’s new target market?
Taking a cue from Apple and Coca-Cola, pharmaceutical firms are humanizing their brands Version française Montreal, February 4, 2014 — By 2018, it is estimated that the global pharmaceutical market will be worth more than $1.3… Read More ›
Swine flu pandemic media pundits with pharma links more likely to talk up risks and promote drugs
Contact: Stephanie Burns sburns@bmj.com 44-020-738-36529 BMJ-British Medical Journal Competing interests should be declared — and reported — to maintain credibility of public health, say researchers Academics with links to the pharmaceutical industry were more likely to talk up the… Read More ›
Drug companies paid big bucks to attend FDA painkiller meetings
Article by: Peter Whoriskey Washington Post October 6, 2013 – 11:15 PM WASHINGTON – A scientific panel that shaped the federal government’s policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical companies that paid… Read More ›
Pricing scandal sees NHS pay £89 for cod-liver oil capsules
Taxpayers are being charged up to 40 times the usual cost for common over-the-counter products being prescribed by NHS doctors, The Telegraph can disclose. The NHS confirmed that inflated prices were being paid by taxpayers and announced the situation was… Read More ›
NHS hit for millions by overcharging ‘scam’
Drug companies exploit loophole in the law to hike prices by as much as 2,000 per cent Sanchez Manning Sunday, 14 July 2013 Drugs companies have been accused of “highway robbery” of the NHS by using a legal loophole to… Read More ›
FDA – 2012 law now in effect which lifts conflict of interest restrictions on FDA advisory panels
Contact: Kathy Fackelmann kfackelmann@gwu.edu 202-994-8354 George Washington University School of Public Health and Health Services Conflict-of-interest restrictions needed to ensure strong FDA review Panel members with ties to industry might lead to approval of unsafe drugs, new analysis suggests WASHINGTON,… Read More ›
Drugs giants used Communist East Germany for ‘illegal’ trials
Several patients died in tests made possible by massive payoffs to Communist regime Tony Paterson Sunday, 12 May 2013 Leading Western pharmaceutical companies paid millions of pounds to former Communist East Germany to use more that 50,000 patients in state-run… Read More ›
‘Medical stocks are down by 90 percent’: Greece accuses pharma giants of slashing imports
Published time: February 28, 2013 01:36 AFP Photo / Louisa Gouliamaki The Greek government has reportedly accused 50 leading pharmaceutical companies of cutting off supplies of key medications to the country, sparking a run on pharmacies. Drug companies say… Read More ›
Study finds that ‘Big Pharma’ fails at self-policing ED drug advertising: Sex, lies and television?
“The mechanism set up by PhRMA for consumers to make complaints does not function: the FAX machine is typically not connected and complaints go unanswered.” Contact: Buffie Stephens buffiestephens@uncc.edu 704-687-5830 University of North Carolina at Charlotte CHARLOTTE, N.C. –Feb…. Read More ›
‘Bad Pharma’ says we’re all victims of drug industry
By Stephen Curry, The Guardian Monday, December 24, 2012 11:11 EST Topics: clinical trials You should read it because behind the anodyne cover lurks a tale of horrific fascination that affects us all. Bad Pharma is the story of… Read More ›
Pharmaceuticals: A market for producing ‘lemons’ and serious harm
2010 study posted for filing Contact: Daniel Fowler fowler@asanet.org 202-527-7885 American Sociological Association Incentives and protections for industry encourage development of many drugs with few new benefits over existing pharmaceuticals, but with risk of serious harm to users ATLANTA —… Read More ›
Drugs giant Novartis warns jobs may go overseas: said bringing a drug to an NHS trust, securing clinical trials and getting approval, is inefficient and takes too long
The Government must tackle the red-tape and research hold-ups hampering Britain’s pharmaceutical industry or risk seeing jobs and investment disappear overseas, one of the industry’s leading companies has warned. Novartis global finance director Jon Symonds said that while the UK… Read More ›
Documentary Evidence Reveals Motives of Pharmaceutical “Seeding” Trials
Re-Post for filing 2008 Clinical studies that are designed by pharmaceutical companies to promote use of their drugs are called “seeding” trials. While much has been written about the marketing tactics of the pharmaceutical industry, seeding trials have not been… Read More ›
Half of drugs prescribed in France useless or dangerous, say two specialists
The doctors claim that the state wastes money on unnecessary medicine that they blame for up to 20,000 deaths annually Kim Willsher in Paris guardian.co.uk, Friday 14 September 2012 12.18 EDT Half of all prescribed drugs are useless or dangerous, two leading… Read More ›
How drug companies exaggerate research costs to justify absurd profits
The Make-Believe Billion By Timothy Noah|Posted Thursday, March 3, 2011, at 9:19 PM ET Reposted at Request March 3, 2011 Donald W. Light of the University of Medicine and Dentistry of New Jersey For years the government has sought to… Read More ›
Osteoporosis Drugs, Reduce Fracture Risk by ONLY 0.9% according to studies
Contact: Emma Dickinson edickinson@bmj.com 44-020-738-36529 BMJ-British Medical Journal Value of drugs for pre-osteoporosis exaggerated Drugs for pre-osteoporosis: Prevention or disease-mongering? Public release date: 17-Jan-2008 A series of recent scientific publications have exaggerated the benefits and underplayed the harms of drugs… Read More ›
How much of the medical literature is shaped behind the scenes by drug companies?
Requested Repost Citation: Sismondo S (2007) Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry” PLoS Med 4(9): e286 Drug companies control or shape multiple steps in the research, analysis, writing,… Read More ›
Drugs companies ‘are putting profits ahead of medical discoveries’, claims hard-hitting report
For every £1 spent on basic research a whopping £19 is spent on marketing, claim experts Current reward system discourages innovation, they add By Claire Bates PUBLISHED:10:13 EST, 8 August 2012| UPDATED:11:08 EST, 8 August 2012 Read more: http://www.dailymail.co.uk/health/article-2185437/Drugs-companies-putting-profits-ahead-medical-discoveries.html#ixzz23E8u5ocy The… Read More ›
Drug company funding of drug trials greatly influences outcome – 35x Better Outcome if Funded by the Drug Company
Contact: Wallace Ravven wravven@pubaff.ucsf.edu 415-476-2557 University of California – San Francisco Drug company funding of drug trials greatly influences outcome In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study,… Read More ›
Engineering Evil 